Safety Announcement Issued by FDA to Investigate Risk of Stroke, Heart Attack and Death for Men Usin

Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, reports that the FDA has issued a Safety Announcement that it will investigate the risk of stroke, heart attack, and death for men using testosterone products. St. Louis, MO (PRWEB) March 16, 2014 On January 31, 2014, the FDA issued a Safety Announcement that it will investigate the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products. The FDA reported that they have “been monitoring this risk and decided to reassess this safety issue based on the recent publication of two separate studies
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations